Relay Therapeutics, Inc. (RLAY) Net income 2019–2025
Relay Therapeutics, Inc. (RLAY) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$276.5MFY2025 · since FY2019: -$75.3M → -$276.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$276.5M | +18.1% |
| FY2024 | -$337.7M | +1.2% |
| FY2023 | -$342.0M | -17.7% |
| FY2022 | -$290.5M | +20.2% |
| FY2021 | -$363.9M | -594.3% |
| FY2020 | -$52.4M | +30.4% |
| FY2019 | -$75.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RLAY financial trends
RLAY RevenueRLAY Net marginRLAY Gross profitRLAY Gross marginRLAY Operating incomeRLAY Operating marginRLAY Operating cash flowRLAY Free cash flowRLAY Capital expendituresRLAY Return on equityRLAY Stock buybacksRLAY Dividends paidRLAY Total assetsRLAY Total liabilitiesRLAY Shareholders’ equityRLAY overview →